BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33790399)

  • 1. Enhanced lipid metabolism induces the sensitivity of dormant cancer cells to 5-aminolevulinic acid-based photodynamic therapy.
    Nakayama T; Sano T; Oshimo Y; Kawada C; Kasai M; Yamamoto S; Fukuhara H; Inoue K; Ogura SI
    Sci Rep; 2021 Mar; 11(1):7290. PubMed ID: 33790399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.
    Nakayama T; Otsuka S; Kobayashi T; Okajima H; Matsumoto K; Hagiya Y; Inoue K; Shuin T; Nakajima M; Tanaka T; Ogura SI
    Sci Rep; 2016 Nov; 6():36478. PubMed ID: 27857072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
    Nakayama T; Nozawa N; Kawada C; Yamamoto S; Ishii T; Ishizuka M; Namikawa T; Ogura SI; Hanazaki K; Inoue K; Karashima T
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101893. PubMed ID: 32592910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
    Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
    Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
    Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
    Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel Schiff base derivative for enhancing the anticancer potential of 5-aminolevulinic acid-based photodynamic therapy.
    Shinohara Y; Endo Y; Abe C; Shiba I; Ishizuka M; Tanaka T; Yonemura Y; Ogura SI; Tominaga M; Yamada H; Uto Y
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():182-188. PubMed ID: 29056554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
    Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
    Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
    van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
    J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
    Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [5-Aminolevulinic acid esters based photodynamic therapy].
    Zhang S; Zhang Z; Jiang D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
    Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
    Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-Organic Layer Delivers 5-Aminolevulinic Acid and Porphyrin for Dual-Organelle-Targeted Photodynamic Therapy.
    Luo T; Fan Y; Mao J; Jiang X; Albano L; Yuan E; Germanas T; Lin W
    Angew Chem Int Ed Engl; 2023 May; 62(22):e202301910. PubMed ID: 36997341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.
    Sinha AK; Anand S; Ortel BJ; Chang Y; Mai Z; Hasan T; Maytin EV
    Br J Cancer; 2006 Aug; 95(4):485-95. PubMed ID: 16868543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDT-induced epigenetic changes in the mouse cerebral cortex: a protein microarray study.
    Demyanenko SV; Uzdensky AB; Sharifulina SA; Lapteva TO; Polyakova LP
    Biochim Biophys Acta; 2014 Jan; 1840(1):262-70. PubMed ID: 24055374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of 5-aminolevulinic acid-based photodynamic therapy protocol for breast cancer cells.
    Guney Eskiler G; Deveci Ozkan A; Sozen Kucukkara E; Kamanlı AF; Gunoğlu B; Yıldız MZ
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101854. PubMed ID: 32512246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoirradiation after aminolevulinic acid treatment suppresses cancer cell proliferation through the HO-1/p21 pathway.
    Nakayama T; Kobayashi T; Shimpei O; Fukuhara H; Namikawa T; Inoue K; Hanazaki K; Takahashi K; Nakajima M; Tanaka T; Ogura SI
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():10-17. PubMed ID: 31404677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid.
    Hayashi M; Fukuhara H; Inoue K; Shuin T; Hagiya Y; Nakajima M; Tanaka T; Ogura S
    PLoS One; 2015; 10(3):e0122351. PubMed ID: 25822972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.